The approval of Wakix marks the first time a non-routine treatment option has been approved for excessive daytime sleepiness in patients aged 6 years and older.
FDA Approves Harmony Biosciences’ Waxix to Treat Excessive Daytime Sleepiness in Pediatric Patients with Narcolepsy
Leave a Comment
